Tuberculosis treatment success rate in Andorra
Andorra: Tuberculosis treatment success rate was 100.0% in 2022. ▲ Rising
Tuberculosis treatment success rate in Andorra, 1998–2022
Source: WHO (2025) – with minor processing by Our World in Data. Measured in %.
Analysis
Andorra recorded 100.0% for tuberculosis treatment success rate in 2022. That is the highest value across all 25 years on record.
That represents a change of unchanged over ten years.
Over the whole period, tuberculosis treatment success rate in Andorra peaked at 100.0% in 1998 and was at its lowest, 50.0%, in 2000.
That places Andorra 1st out of 206 countries with data for 2022, putting it in the top 10%.
The long-run direction has been consistently rising across the 25 years of available data.
Tuberculosis treatment success rate in Andorra, year by year
| Year | % | Change |
|---|---|---|
| 1998 | 100.0% | — |
| 1999 | 67.0% | -33.0% |
| 2000 | 50.0% | -25.4% |
| 2001 | 100.0% | +100.0% |
| 2002 | 100.0% | +0.0% |
| 2003 | 100.0% | +0.0% |
| 2004 | 80.0% | -20.0% |
| 2005 | 89.0% | +11.2% |
| 2006 | 80.0% | -10.1% |
| 2007 | 100.0% | +25.0% |
| 2008 | 100.0% | +0.0% |
| 2009 | 88.0% | -12.0% |
| 2010 | 86.0% | -2.3% |
| 2011 | 100.0% | +16.3% |
| 2012 | 100.0% | +0.0% |
| 2013 | 60.0% | -40.0% |
| 2014 | 83.0% | +38.3% |
| 2015 | 100.0% | +20.5% |
| 2016 | 75.0% | -25.0% |
| 2017 | 100.0% | +33.3% |
| 2018 | 100.0% | +0.0% |
| 2019 | 60.0% | -40.0% |
| 2020 | 100.0% | +66.7% |
| 2021 | 100.0% | +0.0% |
| 2022 | 100.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 83.5% | 67.0% | 100.0% | 2 |
| 2000s | 88.7% | 50.0% | 100.0% | 10 |
| 2010s | 86.4% | 60.0% | 100.0% | 10 |
| 2020s | 100.0% | 100.0% | 100.0% | 3 |
Countries ranked near Andorra
- 1 American Samoa 100.0% compare
- 1 Barbados 100.0% compare
- 1 Bermuda 100.0% compare
- 1 British Virgin Islands 100.0% compare
- 1 Cayman Islands 100.0% compare
- 1 Cook Islands 100.0% compare
- 1 Palestine, State of 100.0% compare
- 1 Saint Kitts and Nevis 100.0% compare
- 1 Samoa 100.0% compare
- 1 Sint Maarten (Dutch part) 100.0% compare
- 1 Tonga 100.0% compare
- 1 Turks and Caicos Islands 100.0% compare
More health data for Andorra
- Estimated changes in temperature-related death rates compared to projected death rates 1,824 deaths per 1,000 people (2090)
- Heat deaths vs projected death rates, annual growth rate 0.0878 % change on previous year (2090)
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2077)
- Number of infants who die before age 1 0 deaths (2100)
- Age population, age 09, male, interpolated 371 (2025)
- Population, male 42,360 (2025)
- Age population, age 09, female, interpolated 345 (2025)
- Age population, age 08, male, interpolated 358 (2025)
- Age population, age 08, female, interpolated 329 (2025)
- Age population, age 07, male, interpolated 329 (2025)
Frequently asked questions
- What is tuberculosis treatment success rate in Andorra?
- Tuberculosis treatment success rate in Andorra was 100.0% in 2022, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest tuberculosis treatment success rate recorded in Andorra?
- The highest recorded value was 100.0% in 1998.
- What is the lowest tuberculosis treatment success rate recorded in Andorra?
- The lowest recorded value was 50.0% in 2000.
- How does Andorra rank for tuberculosis treatment success rate?
- Andorra ranks 1st out of 206 countries with data for 2022.
- Is tuberculosis treatment success rate rising or falling in Andorra?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Andorra data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Tuberculosis treatment success rate. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Treatment success rate among new and relapse cases.